1.	The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients Phase: Phase III Type: Supportive care Status: Active Age: 1 to 21 Sponsor: Other Protocol IDs: 06-08-367, NCT00726934
2.	Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000651536, RTOG-0920, NCT00956007
3.	Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 09-039, NCT00994110
4.	Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy Phase: Phase III Type: Supportive care, Tissue collection/Repository Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000684240, NCCTG-N08C9, N08C9, NCT01198145
5.	Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Active Age: 6 months to 21 years Sponsor: NCI, Other Protocol IDs: CDR0000695661, COG-ACCL0934, ACCL0934, NCT01371656
6.	Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GWCA0999, 2009-016529-32, NCT01337089
7.	Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-070, NCT01491698
8.	A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: AAA-III-01, 2011-005049-11, NCT01578239
9.	Proton Therapy vs. IMRT for Low or Low-Intermediate Risk Prostate Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 11-497, NCT01617161
10.	Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000738944, RTOG-1203, NCT01672892
11.	TELESTAR (Telotristat Etiprate for Somatostatin Analogue Refractory Carcinoid Syndrome) Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LX1606.1-301-CS, LX1606.301, NCT01677910
12.	Accelerating Gastrointestinal Recovery Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 12-004082, NCT01704651
13.	ADAM-Afatinib Diarrhea Assessment and Management Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 1200.167, NCT01814553
14.	Managing Medication-induced Constipation in Cancer: A Clinical Trial Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: MCC-15712, NCT01416909
15.	The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer Phase: Phase II, Phase I Type: Supportive care Status: Active Age: Not specified Sponsor: Pharmaceutical / Industry Protocol IDs: SAL 2012-0584, NCT01739634
16.	Acupuncture in Reducing Ileus in Patients Who Have Undergone Surgery for Colorectal Cancer Phase: Phase II Type: Supportive care Status: Active Age: Over 18 Sponsor: NCI Protocol IDs: MSKCC-06145, NCT00425412
17.	Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000533887, RTOG-0526, NCT00450411
18.	Methylnaltrexone for Opioid-induced Constipation in Cancer Patients Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VCC 0911, NCT01004393
19.	Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer Phase: Phase II Type: Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: C7135-R, RX000152-01A1, NCT01032928
20.	Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000690182, RTOG-1012, NCT01262560
21.	Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 14989, NCT01301495
22.	Study Of Dacomitinib In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A7471042, NCT01465802
23.	Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 4P-11-3, NCI-2011-03266, NCT01469338
24.	Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 andover Sponsor: Other Protocol IDs: IRB00008071, CPC-12095-L, NCI-2012-02780, NCT01748942
25.	Rocking Motion: Physiologic Effect on the Surgical Stress Response Phase: Phase I Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2010-0129, NCT01200316